Funding daily

Biotech Startup Prilenia Picked up $43 Million in a Series B Funding Round

What is Prilenia?

Prilenia is a biotechnology services provider.

What does Prilenia do?

The company develops treatments for neurodegenerative and neurodevelopmental disorders.

Who owns Prilenia?

Michael R Hayden founded Prilenia in 2018.

How much has Prilenia raised?

The company picked up $43 million in a Series B funding round that brings the company’s total financing to $105.5 million in funding over 2 rounds.

Who has invested in Prilenia?

ALS Investment Fund and 6 other investors backed the latest investment round.

What domain name does Prilenia operate on?

You can see Prilenia mean business by looking at their domain name choices – the brand has secured Prilenia.com, an exact brand match name with the global .com extension.

Related reads

Biotech company LYNK Pharmaceuticals raised $50 million in Series B round

13 Entrepreneurs explain how they came up with their brand name

The fastest-growing companies in the World and their domain name choices

20 Biohacking companies worth watching in 2021/2022 and their domains

Related Articles

Advertisement

Tsani Gramatikova

An extroverted introvert who enjoys reading, cooking and just chilling.
Back to top button